The Supreme Court limited the Environmental Protection Agency’s (EPA) ability to regulate carbon emissions from power plants on Thursday, ruling 6-3 that “Congress had […]
Supreme Court limits EPA’s ability to reduce power plant emissions Read More »
The House Appropriations Committee is set to mark up today the fiscal year 2023 spending bill for Health and Human Services (HHS), which would
Healthcare spending bill draft includes many BIO requests Read More »
As monkeypox virus cases increase in the United States, the Biden administration will begin distributing the monkeypox vaccine around the country, focusing on persons
U.S. to distribute 1.6 million doses of monkeypox vaccine by year’s end Read More »
The Vaccine and Related Biological Products Advisory Committee (VRBPAC) of the Food and Drug Administration (FDA) voted 19-2 in favor of including Omicron variants
FDA advisers call for Omicron-specific boosters Read More »
The Bayh-Dole Act was meant to encourage innovative research. However, some lawmakers are trying to change the intent of the law using the “march-in
‘Backdoor’ drug price controls will limit access to medicines, says expert Read More »
The FDA’s Accelerated Approval pathway has assisted America’s biotech industry in making remarkable advances over the last 30 years—but it has come under political
Accelerated Approval is under political attack, experts say Read More »
On April 13, the U.S. Food and Drug Administration (FDA) released new draft guidance for industry on “creating strategies to recruit additional participants from underrepresented
BIO recommends improvements to FDA’s clinical trial diversity guidance Read More »
In a letter to the leaders of the Senate Agricultural Committee, the Biotechnology Innovation Organization (BIO) and dozens of other food and agriculture groups
BIO, ag industry groups support Alexis Taylor for USDA Under Secretary Read More »
On June 22, the Senate Commerce Committee approved BIO-supported legislation intended to increase transparency of the business practices of pharmacy benefit managers (PBMs), which
Senate Committee advances PBM transparency legislation Read More »
While some US federal regulators believe the ongoing intensification of mergers and acquisitions in various sectors could jeopardize market competition, M&As can be beneficial
M&As in biotech can help patients, says AskBio Read More »
